Deletion of the Developmentally Essential Gene ATR in Adult Mice Leads to Age-Related Phenotypes and Stem Cell Loss  by Ruzankina, Yaroslava et al.
Cell Stem Cell
ArticleDeletion of the Developmentally Essential
Gene ATR in Adult Mice Leads to Age-Related
Phenotypes and Stem Cell Loss
Yaroslava Ruzankina,1,4 Carolina Pinzon-Guzman,1,4 Amma Asare,1 Tony Ong,1 Laura Pontano,1
George Cotsarelis,2 Valerie P. Zediak,3 Marielena Velez,3 Avinash Bhandoola,3 and Eric J. Brown1,*
1 Abramson Family Cancer Research Institute, Department of Cancer Biology
2 Department of Dermatology
3 Department of Pathology and Laboratory Medicine
University of Pennsylvania School of Medicine, 421 Curie Boulevard, Philadelphia, PA 19104-6160, USA
4 These authors contributed equally to this work.
*Correspondence: brownej@mail.med.upenn.edu
DOI 10.1016/j.stem.2007.03.002SUMMARY
Developmental abnormalities, cancer, and pre-
mature aging each have been linked to defects
in the DNA damage response (DDR). Mutations
in the ATR checkpoint regulator cause develop-
mental defects in mice (pregastrulation lethal-
ity) and humans (Seckel syndrome). Here we
show that eliminating ATR in adult mice leads
to defects in tissue homeostasis and the rapid
appearance of age-related phenotypes, such
as hair graying, alopecia, kyphosis, osteoporo-
sis, thymic involution, fibrosis, and other ab-
normalities. Histological and genetic analyses
indicate that ATR deletion causes acute cellular
loss in tissues in which continuous cell prolifer-
ation is required for maintenance. Importantly,
thymic involution, alopecia, and hair graying
in ATR knockout mice were associated with
dramatic reductions in tissue-specific stem
and progenitor cells and exhaustion of tissue
renewal and homeostatic capacity. In aggre-
gate, these studies suggest that reduced
regenerative capacity in adults via deletion of
a developmentally essential DDR gene is suffi-
cient to cause the premature appearance of
age-related phenotypes.
INTRODUCTION
DNA damage response (DDR) genes are essential for
maintenance of genomic integrity. Mutations in many
DDR genes have been linked to disorders that are pre-
dominantly associated with failures in development.
These syndromes are typically characterized by micro-
cephaly, mental and growth retardation, skeletal abnor-
malities, and dysmorphic facial features. The DDR genes
linked to these diseases possess a variety of functions inDNA repair and checkpoint signaling (O’Driscoll and
Jeggo, 2006) and include BLM (Bloom’s syndrome),
FANC genes (Fanconi anemia), NBS (Nijmegen breakage
syndrome), LIG4 (LIG4 syndrome), and ATR (Seckel syn-
drome). However, mutations in DDR genes are also asso-
ciated with progeroid syndromes that phenocopy aspects
of normal aging, e.g., Werner syndrome, Cockayne syn-
drome, trichothyodystrophy, dyskeratosis congenita, and
ataxia-telangiectasia (Kipling et al., 2004). Progeroid
syndromes such as these suggest that, in addition to
appropriate development, DDR genes are important for
preventing age-related diseases.
The function of DDR genes in assuring normal develop-
ment and preventing age-related diseases has been fur-
ther elucidated by gene-targeting studies in mice (Hasty
et al., 2003; Lombard et al., 2005). Again, these studies
have shown that DDR mutations lead to a variety of disor-
ders, including developmental failures, increased cancer
incidence, and accelerated aging (Lombard et al., 2005;
O’Driscoll and Jeggo, 2006). For example, while deletion
of BRCA1, XPD, or XRCC4 causes embryonic lethality, hy-
pomorphic mutations in these same genes in combination
with genetic backgrounds that permit the completion of
embryonic development lead to a broad range of age-
related phenotypes (Cao et al., 2003; Chao et al., 2006;
de Boer et al., 2002). Thus, the presentation of age-related
phenotypes and developmental abnormalities appear to
vary in a manner that depends on the function of the
gene (specific type of DNA repair, checkpoint role, etc.),
the cell type in which this function is particularly required,
and whether the mutation is null or hypomorphic.
In humans, hypomorphic mutations in the ATR (ATM-
and Rad3-related) protein kinase have been linked to
Seckel syndrome, a disease characterized by severe
growth retardation, microcephaly, and facial and osteos-
keletal abnormalities (O’Driscoll and Jeggo, 2006; O’Dris-
coll et al., 2003). As a central upstream regulator of cellular
responses to replication stress and DNA damage, ATR
phosphorylates BRCA1, Chk1, BLM, p53, and other
DDR factors to inhibit cell cycle progression and assure
genome maintenance (Osborn et al., 2002). While ATRCell Stem Cell 1, 113–126, July 2007 ª2007 Elsevier Inc. 113
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ATR Deletion Causes Aging Phenotypesheterozygous mice develop normally and demonstrate
a significantly increased tumor risk by 18 months of age
(Brown and Baltimore, 2000), homozygous elimination of
ATR leads to chromosome breaks, proliferative failure in
culture, and early embryonic lethality (Brown and Balti-
more, 2000; Cortez et al., 2001; de Klein et al., 2000).
The effect of ATR loss on cell proliferation is consistent
with findings indicating that ATR and ATR orthologs in
other organisms play an especially important role in main-
taining genome integrity during DNA synthesis (Brown and
Baltimore, 2003; Casper et al., 2002; Lopes et al., 2001),
putatively by stabilizing stalled DNA replication forks and
preventing their collapse into double-strand breaks
(Osborn et al., 2002). Because chromosome breaks are
observed in cultured ATR knockout cells even in the
absence of exogenous replication stress (Brown and
Baltimore, 2000, 2003; Casper et al., 2002), stalled DNA
replication may be a common event during normal cellular
proliferation.
Because ATR is essential for embryonic development,
the effect of ATR deletion in adult mice has not been
tested previously. Herein, we demonstrate that ATR dele-
tion in adult animals leads to the rapid onset of a broad
range of age-related phenotypes that coincides with
stem and progenitor cell depletion and exhaustion of tis-
sue renewal and homeostatic capacity. Interestingly, re-
ports of skin degeneration, alopecia, premature hair gray-
ing, and hematopoietic defects have been previously
noted in some Seckel patients (Arnold et al., 1999; Bo-
scherini et al., 1981; Butler et al., 1987; Fathizadeh et al.,
1979). Our studies suggest that maintenance of tissue ho-
meostasis and regeneration remain important for prevent-
ing aging throughout adulthood and may be a common
means by which ATR and other developmentally essential
DDR genes prevent age-related phenotypes.
RESULTS
Generation of Cre-ERT2 Transgenic Mice
to Conditionally Delete ATR
To circumvent embryonic lethality and determine the ef-
fect of ATR loss on adult mice, a Cre-ERT2 transgenic
mouse line was generated through lentitransgenesis
(Lois et al., 2002) using a lentivirus that expresses the
Cre-ERT2 from the human ubiquitin C promoter (Fig-
ure 1A). Cre-ERT2 is a fusion protein composed of Cre
recombinase and a mutant form of the estrogen receptor
that is selectively activated only in the presence of tamox-
ifen (TAM), but not estrogen (Feil et al., 1997). In com-
bination with a flox-conditional allele of ATR (Brown and
Baltimore, 2003), the Cre-ERT2 line provides a system to
efficiently delete ATR both spatially and temporally in the
mouse.
A Cre-ERT2 mouse line with a single integrated copy of
the virus was chosen for further analysis (Figure 1B). To
test the efficiency of Cre recombinase activation, adult
ATRflox/+Cre-ERT2+ mice (8–12 weeks of age) were
treated once per day for 5 days with TAM by oral gavage
(Figure 1C). Three days after the final treatment, mice were114 Cell Stem Cell 1, 113–126, July 2007 ª2007 Elsevier Inc.sacrificed and DNA from a variety of tissues was analyzed
by Southern hybridization to quantify the ATR+, ATRflox,
andATRD alleles (Figures 1D and 1E). Efficient recombina-
tion (>70%) was observed in all tissues examined (Fig-
ure 1E) including the intestine, liver, pancreas, and lung
(Figure 4C and data not shown). Thus, the Cre-ERT2
mouse line provides a system to conditionally activate
Cre recombinase in a wide range of tissues upon TAM
treatment. In addition, because the flox allele remained
unrecombined in a small percentage of cells in all tissues
examined (Figures 1E and 4C), this system allowed pro-
duction of mice that are mosaic for ATRflox recombination.
Age-Related Phenotypes in ATRmKO Mice: Hair
Loss and Graying, Kyphosis, Osteoporosis, Fibrosis
of the Heart and Kidney, Reduced Thymopoiesis,
and Spermatogenesis
ATR mosaic knockout (ATRmKO) mice were generated
by TAM treatment of ATRflox/Cre-ERT2+ at 8–12 weeks
of age (Figure 1C) and were compared to TAM-treated
ATRflox/+Cre-ERT2+ (control) mice. Within 3–4 months af-
ter TAM treatment, several age-related phenotypes were
observed in ATRmKO mice including pervasive hair graying
and alopecia (n = 43), which continued to increase in ex-
pressivity for more than 1 year after treatment (Figure 2A).
The extent of hair graying far exceeded that observed in
normally aged mice. In contrast, no obvious phenotypes
were observed in control mice (n = 50), which remained
similar in appearance to untreated age-matched litter-
mates. In comparison to control skin, thinning of the sub-
cutaneous adipose layer (up to 70% reduced), thickening
of the epidermis, and loss of hair follicles were observable
within 3–6 months of TAM treatment in ATRmKO mice;
these abnormalities consistently progressed to greater
severity subsequently (Figure 2B). Similar phenotypes
have been documented in aging humans and in previously
described mouse models of aging (Hasty et al., 2003;
Lombard et al., 2005). The follicles remaining in ATRmKO
mice often yielded gray hair shafts and displayed ab-
normal architecture, such as sebaceous gland cell hyper-
trophy and degeneration of dermal and epidermal struc-
tures (Figure 2B and data not shown). Finally, single
topical application of 4-hydroxytamoxifen (4-OHT) to a
1–2 cm2 patch of skin caused localized alopecia and
gray hair regrowth in ATRflox/-Cre-ERT2+ mice, but not in
ATRflox/+Cre-ERT2+ control mice (see Figure S1 in the
Supplemental Data available with this article online). To-
gether, these results indicate that ATR is required to pre-
vent age-related phenotypes in the hair and skin.
Other common characteristics of aging in humans and
mice are increased kyphosis (an abnormal rearward
curvature of the spine), weight loss, and osteoporosis
(Hasty et al., 2003; Lombard et al., 2005). By simple visual
inspection, ATRmKO mice 3 months to 1 year following
TAM treatment displayed significantly increased kyphosis
in comparison to control mice (Figure 2A). This phenotype
was accompanied by a decrease in the total body weight.
Body weight averages for ATRmKO were 20% lower than
control mice by 1 year after treatment (21.3 ± 3.2 g for
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ATR Deletion Causes Aging PhenotypesFigure 1. A Drug-Inducible System to Delete ATR in Adult Mice
(A) Lentiviral construct used to generate Cre-ERT2 fusion protein-expressing lentivirus.
(B) A founder with a single-copy integrant that expressed high levels of Cre-ERT2 was chosen to establish Cre-ERT2 lentitransgenic mouse line
(arrow).
(C) TAM treatment regimen used to stimulate recombination of the ATRflox allele. Mice were treated TAM at 2–3 months of age by oral gavage or
intraperitoneal injection and analyzed subsequently at various time points.
(D) Schematic of the ATRflox region (Brown and Baltimore, 2003). The kinase domain-encoding exons (KD1 and KD2) and probed region are shown.
The null allele of ATR (ATR) is wild-type in this probed region.
(E) Southern blot of genomic DNA isolated from TAM-treated ATRflox/+Cre-ERT2+ mice. DNA samples from various tissues were digested with SphI
and KpnI, Southern blotted, and detected for the ATRflox region using the probe indicated in (D). SphI ATRflox allele fragment = 3.1 kb, SphI ATRD allele
fragment = 1.8 kb.ATRmKO mice versus 26.6 ± 3.1 g for control mice, p =
0.0006). To confirm that the apparent kyphosis in ATRmKO
mice was not a visual artifact produced by reduced body
fat, ATRmKO and control mice were analyzed by X-ray 1
year after TAM treatment. In all mice analyzed, ATRmKO
mice displayed a higher degree of kyphosis compared
to that observed in control mice (Figure 2C). These data
indicate that ATR loss leads to kyphosis in adult mice.In humans, kyphosis is associated with bone degenera-
tion. To test if ATR deletion leads to osteoporosis, femurs
from ATRmKO mice and control mice 1 year after TAM
treatment were analyzed for cortical and trabecular bone
volume and architecture. In comparison to control mice,
femurs ofATRmKO mice displayed an 18% decrease in cor-
tical bone cross-sectional area (p = 0.0001) and 46%–
76% reduction in trabecular bone volume (p = 0.04) asCell Stem Cell 1, 113–126, July 2007 ª2007 Elsevier Inc. 115
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ATR Deletion Causes Aging PhenotypesFigure 2. ATR Deletion Leads to Hair Graying, Alopecia, Kyphosis, and Osteoporosis
(A) ATR deletion following TAM treatment leads to pervasive hair graying and patchy hair loss and kyphosis in ATRmKO mice.116 Cell Stem Cell 1, 113–126, July 2007 ª2007 Elsevier Inc.
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ATR Deletion Causes Aging PhenotypesFigure 3. Reduced Thymopoiesis, Accelerated Thymic Involution, and Failed Spermatogenesis in ATRmKO Mice
(A) Quantification of thymocytes at differing time points after ATR deletion. Thymi from ATRmKO and control animals (6–12 mice per group) were pro-
cessed through mesh, and thymocytes were counted by hemacytometer. Standard error bars are shown; p values were calculated by Student’s t test.
NS, not significant.
(B) Premature thymic involution in ATRmKO mice. A significant reduction in the volume of stromal cortical layer, where early T cell precursors reside,
was observed in all ATRmKO mice analyzed 1 year after ATR deletion (n = 3, double arrow). K5, medullary epithelium; K8, cortical epithelium.
(C) Testicular degeneration in ATRmKO mice. Dramatic testicular atrophy was observed in all ATRmKO mice examined (n = 7), but not in control mice
(n = 5). Pictures in (B) and (C) were taken at 1003 magnification.determined by micro-CT (Figure 2C) and histomorpho-
metric analyses (data not shown). In aggregate, these
data indicate that ATR deletion leads to kyphosis and
osteoporosis in adult mice.
Thymic involution is a hallmark of hematopoietic aging
and is associated with decreased thymocyte abundance
and deterioration of the thymic stroma (Zediak and Bhan-
doola, 2005). Consistent with the appearance of other
age-related phenotypes (above), premature suppressionof thymocyte abundance was observed in ATRmKO mice
in comparison to control mice (Figure 3A). Thymocyte
numbers in ATRmKO mice declined precipitously 1–2
weeks after TAM treatment. Although thymocyte numbers
largely recovered within 3 months, they were again ob-
served to be significantly suppressed 6 months to 1 year
after TAM treatment (Figure 3A). Of note, thymocyte abun-
dance in ATRmKO mice 6 months after ATR deletion was
comparable to that observed in control mice 12–14(B) Age-related abnormalities in the skin of ATRmKO mice. Thinning of the subcutaneous adipose layer (A), thickening of the epidermis (E), loss of hair
follicles (F), and sebaceous gland cell hypertrophy (S) were observed in ATRmKO mice (n = 19), but not in control mice (n = 22). Sections from sex-
matched mice are shown.
(C) Increased kyphosis and osteoporosis in ATRmKO mice. Control and ATRmKO mice were X-rayed 1 year after TAM treatment (left panel). Increased
kyphosis over controls was observed in allATRmKO mice analyzed (n = 6). To analyze bone volume and cross-sectional area, femurs fromATRmKO and
control mice were subjected to microCT analysis (four to seven mice analyzed per group). Trabecular bone in the distal metaphysic (middle panel) and
cortical bone cross-sectional area (right panel) was imaged and analyzed. Bone volume/total volume (BV/TV) and cortical area are shown as
mean ± SD. P% 0.04 as calculated by Student’s t test.Cell Stem Cell 1, 113–126, July 2007 ª2007 Elsevier Inc. 117
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age-associated decrease in thymocyte numbers occurred
significantly earlier in ATRmKO mice.
Age-associated architectural deterioration of the thymic
stroma was also observed prematurely in ATRmKO mice.
The thymus is comprised of the cortex, in which early T
cell precursors undergo differentiation, and the medulla,
which harbors more mature T cell progenitors. Aged thymi
exhibit cellular damage and architectural disruption pre-
dominantly in the cortical layer (Nabarra and Andrianari-
son, 1996). A significant reduction in the total thymus
volume, particularly in the thickness of the cortical layer
(1.5- to 2-fold), was observed in the thymi of ATRmKO mice
in comparison to control mice (Figure 3B). Together, these
data indicate thatATR loss affects cellularity and architec-
ture of the thymus in manners that emulate normal aging.
Several other age-associated disorders were observed
in ATRmKO mice. These disorders included architectural
deterioration and fibrosis in the kidney and heart (Fig-
ure S2) and an early and permanent loss of spermatogen-
esis (Figure 3C). These phenotypes were not observed in
control mice (Figure S2 and Figure 3C). In addition, as pre-
viously reported in other mouse models of aging (Hasty
et al., 2003; Lombard et al., 2005), we observed no sig-
nificant increase in tumor risk in ATRmKO mice compared
to ATR heterozygous control mice. No tumors were ob-
served in any ATRmKO mice in the course of these studies,
even in older cohorts between the ages of 12 and 18
months (n = 17). In contrast, tumors were observed in 3
out of 28 control mice (Table S1), which approximately
represents the frequency expected in ATR heterozygotes
in this age group (Brown and Baltimore, 2000). These data
indicate that complete loss of ATR does not promote
tumorigenesis in vivo.
In summary, deletion of ATR in adult mice leads to
a number of disorders including hair loss and graying, ky-
phosis, osteoporosis, premature involution of the thymus,
fibrosis of the heart and kidney, and decreased spermato-
genesis. Although it is currently not clear whether these
age-related phenotypes ultimately affect longevity, these
disorders present in a manner that is reminiscent of aging
in humans and mice. Taken together, these data indicate
that ATR loss in adult mice causes the premature appear-
ance of age-related phenotypes.
ATR Deletion Leads to Loss of Proliferating Cells
In Vivo
Besides the age-associated phenotypes described
above, we observed a dramatic acute effect of ATR dele-
tion on the intestines ofATRmKO mice. Approximately 80%
of the villus epithelium was lost 1 week after ATR deletion;
however, full recovery was observed 1 month later (Fig-
ure 4A). This effect was not observed in control mice
(Figure 4A). Initial acute loss of intestinal structures was
strongly associated with loss of proliferating cells (BrdU,
Figure 4A), and a similar temporary loss of proliferating
cells after ATR deletion was observed in other organs,
such as skin, kidney, and liver (data not shown). Increased
abundance of apoptotic cells was not detected following118 Cell Stem Cell 1, 113–126, July 2007 ª2007 Elsevier Inc.ATR deletion (data not shown), possibly due to rapid clear-
ance mechanisms. Our findings suggest that, while the
abundance of proliferating cells is compromised in most
tissues following ATR loss, tissue homeostasis affords
some degree of recovery over time.
We hypothesized that, while ATR knockout cells appear
to be lost in the course of proliferation, the ATRflox/ cells
that escape lox recombination may permit some tissue re-
constitution in ATRmKO mice. To examine this possibility,
the ratio of ATRflox and ATRD alleles was assessed by
Southern hybridization at various time points following
ATR deletion. The average deletion rate of the ATRflox
allele in ATRflox/+Cre-ERT2+ mice was high (>80%) in a
variety of tissues 1–2 weeks after TAM treatment, and the
representation of these ATRD/+ cells remained similarly
high for more than 1 year (Figures 1E, 4B, and 4C). Thus,
ATRD/+ cells displayed no observable competitive disad-
vantage in comparison to ATRflox/+ cells in TAM-treated
ATRflox/+Cre-ERT2+ mice. In contrast, the representation
of ATRD/ cells in ATRmKO mice rapidly declined over
time in tissues in which cellular proliferation occurs consti-
tutively and rapidly, such as in the bone marrow, intes-
tines, spleen, and thymus (Figures 4B and 4D). The ob-
served reconstitution of these tissues (Figures 3A and
4A and data not shown) must be attributable to cells that
escaped lox recombination (ATRflox/) and continue to ex-
press ATR. Importantly, representation ofATRD/ cells did
not decrease appreciably in the brain, a tissue in which
cellular proliferation is generally slow (Figure 4D), suggest-
ing that ATR is less important for the continued viability of
nondividing cells. Consistent with this interpretation, dele-
tion of ATR specifically in postmitotic neurons led to
no observable effect on behavior, activity, coordination,
or circadian rhythm (Figure S3). In addition, although a
decrease in ATRD/ cells was observed in the heart and
kidney over time, these tissues also displayed increased
fibrosis (Figure S2), which was likely attributable to fibro-
blasts that escaped lox recombination. Together, these
data indicate that ATR loss in ATRmKO mice leads to the
loss of proliferating cells in vivo and, in some tissues, a
subsequent reconstitution with the cells that escaped
lox recombination and remain ATR positive.
It has been previously observed thatATR deletion in cul-
tured murine embryonic fibroblasts leads to cell cycle exit
in a manner reminiscent of cellular senescence (Brown
and Baltimore, 2003). Therefore, it is within reason that
part of the decreased representation of ATRD/ cells in
vivo may be due to cell cycle exit via senescence. To in-
vestigate this possibility, we examined several tissues
for senescence-associated b-galactosidase (SA-b-gal)
activity and p21 expression, which are established
markers of senescent cells in vivo. In most tissues exam-
ined, including the thymus, intestine, skin, heart, and
brain, no difference in SA-b-gal staining was observed be-
tween ATRmKO and control mice either soon after TAM
treatment or up to 1 year later. High levels of staining in
the red pulp of the spleen and within cortical regions of
the kidney were observed equally in control and ATRmKO
mice, as was staining of specific cell types with high
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ATR Deletion Causes Aging PhenotypesFigure 4. ATR Deletion Leads to Loss of Proliferating Cells in Mice
(A) Rapid loss and reconstitution of proliferating intestinal epithelial cells after ATR deletion. Mice were treated with BrdU in drinking water for up to
1 month following TAM treatment. Loss of proliferating intestinal epithelial cells was observed 1 week after ATR deletion in ATRmKO mice (n = 4); how-
ever, a full recovery was observed 3 weeks later (n = 5). Pictures were taken at 1003 magnification.
(B) ATRD/ cells are rapidly lost in proliferating tissues (bone marrow, intestine), but not in the brain of ATR knockout mice. Southern blot of genomic
DNA isolated from ATRflox/+Cre-ERT2+ (control) and ATRflox/-Cre-ERT2+ (ATRmKO) mice treated or left untreated with TAM. Appearance of the ATRD
allele represents ATRD/+ cells in control mice and ATRD/ cells in test mice.
(C and D) Percentage of ATRD/+ cells remains constant (C), whileATRD/ cells are lost (D) in various tissues following lox recombination. Southern blot
band intensities of lox recombined (ATRD) and unrecombined (ATRflox) were used to quantify the total percentage of cells that maintained a recom-
bined copy of ATR (ATRD). Band intensities were quantified by phosphoimager, and mean percentages were calculated from the ratio ATRD over
ATRD + ATRflox. For each tissue and time point, two to eight mice were evaluated; each error bar indicates one standard deviation.lysosomal content, such as paneth cells in the intestine
and lysing cells of the sebaceous gland in the skin (Fig-
ure S4 and data not shown). In comparison to control
mice, a significant increase in SA-b-gal-stained cells
was found only in the liver of ATRmKO mice 1 year afterATR deletion. Although the widespread appearance of
cells expressing increased levels of p21 were not ob-
served in this tissue or others (Figure S4 and data not
shown), it is formally possible that the increase in ex-
pression of p21 that accompanies senesecence wasCell Stem Cell 1, 113–126, July 2007 ª2007 Elsevier Inc. 119
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ATR Deletion Causes Aging PhenotypesFigure 5. Decreased Levels of Hematopoietic and Thymic Progenitors in ATRmKO Mice
(A) Quantification of hematopoietic LSK (LinSca+c-Kithi) progenitors in the bone marrow of ATRflox/+Cre-ERT2+ (control) and ATRflox/-Cre-ERT2+
(ATRmKO) mice 1 year after TAM treatment. Five to nine mice per group were analyzed.
(B and C) Quantification of T cell progenitors in the thymus of control and test mice. A decline in numbers (B) and frequencies (C) of ETPs
(LinCD25c-Kithi) and DN2 (LinCD25+c-Kithi) was observed in the thymi of ATRmKO mice 1 year after TAM treatment (five to seven mice per group).
Standard error bars are shown; p values were calculated by Mann-Whitney U test.insufficient to be detectable by immunohistochemistry.
We do not rule out the possibilities that senescent cells
in ATRmKO mice may have been generated and subse-
quently cleared (Xue et al., 2007) or were present in small
subpopulations that were not readily identifiable; never-
theless, a widespread accumulation of senescent cells in
ATRmKO mice using the methods described herein was
not observed.
Together, our results indicate that ATR deletion leads to
the loss of ATRD/ cells and a subsequent deterioration of
tissue homeostasis (Figures 2–4). Given these results, we
reasoned that the aging phenotypes observed in ATRmKO
mice do not appear to be the consequence of persistent
ATR knockout cells but, instead, may be caused by im-
paired regenerative capacity and depletion of stem cell
potential. To address these possibilities, we made use of
two systems in which stem cells have been well character-
ized: hematopoiesis/thymopoiesis and the hair follicle
cycle as described below.
Premature Thymic Involution in ATRmKO Mice
Correlates with Thymic Progenitor Cell Attrition
As shown in Figure 3A, ATRmKO mice exhibited a signifi-
cant reduction in thymocyte numbers, indicative of an ac-
celerated involution process. In normal aged mice, thymic
involution is thought to result from deterioration of the
thymic stroma and declining numbers of bone marrow-
derived hematopoietic progenitors and early intrathymic
T cell progenitors (Zediak and Bhandoola, 2005). To deter-
mine if ATRmKO exhibited reductions in T cell progenitor120 Cell Stem Cell 1, 113–126, July 2007 ª2007 Elsevier Inc.populations, the frequencies of T cell precursors in the
bone marrow and thymus were assessed in ATRmKO and
control mice.
LinSca-1+c-Kithi (LSK) stem and progenitor cells in the
bone marrow are early precursors in T cell development
(Zediak and Bhandoola, 2005). In comparison to control
mice, a significant decline in the LSK fraction was ob-
served in the bone marrow of ATRmKO mice 12–13 months
after TAM treatment (Figure 5A). In addition, consistent with
premature thymic involution, the number and frequency
of early T cell progenitors (ETPs, LinCD25c-Kithi) and
downstream double-negative 2 progenitors (DN2,
LinCD25+c-Kithi) were dramatically decreased in the
thymi of ATRmKO mice (Figures 5B and 5C). This observa-
tion is consistent with the previously reported reduction of
ETP frequencies in aged mice (Min et al., 2004) and sug-
gests that the premature thymic involution observed in
ATR knockout mice is caused, at least in part, by progen-
itor cell attrition.
Graying Hair and Alopecia in ATRmKO Mice Are
Associated with Loss of Follicle Bulge Stem Cells
The hair follicle cycle in mice and humans consists of three
major phases: anagen (follicle growth), catagen (follicle re-
gression by apoptosis), and telogen (quiescent resting
phase). Anagen is induced naturally following catagen or
initiated prematurely in telogen by hair depilation, i.e.,
plucking (Ito et al., 2004). During normal telogen-to-
anagen transition or following depilation, follicle bulge
stem cells become activated and proliferate to initiate
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light, depilation may be viewed as an inducible system to
assess hair regenerative capacity.
As described above, hair follicle loss and hair graying
were observed in ATRmKO mice (Figure 2). To test the
effect of ATR loss on the hair follicle cycle, 50- to 55-
day-old (telogen phase) ATRflox/+Cre-ERT2+ control and
ATRflox/-Cre-ERT2+ test mice were treated on 2–3 cm2
patches of skin with 4-OHT. Telogen hair follicles in control
and ATRmKO skin exhibited normal morphology after
4-OHT treatment, indicating that ATR is not required dur-
ing the quiescent phase (Figure S5A). To induce anagen,
mice were depilated on the central 1 cm2 patch of
4-OHT-treated skin. Following depilation, anagen in con-
trol ATRflox/+Cre-ERT2+ mice was initiated and proceeded
normally, as indicated by the enlargement of the dermal
papillae (DP) and elongation of the epithelial strands
above DP (Figure 6A, first depilation). In contrast, early
anagen phase in ATRmKO skin was accompanied by the
widespread appearance of degenerative hair follicles 4
days after depilation and a delay in anagen progression
8 days after depilation (Figure 6A, first depilation). Hair
shaft generation in ATRmKO skin was also delayed and
compromised both in abundance and quality (Figure 6B
and data not shown). Although sufficient regenerative
capacity exists for a majority of hair follicles in ATRmKO
skin, follicle development was significantly delayed.
After a second round of depilation in the subsequent tel-
ogen phase, hair regeneration in ATRmKO skin was more
dramatically affected, both in regards to hair paucity and
the increased representation of gray hair shafts (Fig-
ure 6B). A final third round of depilation once again caused
a profound delay in hair regeneration in ATRmKO regions in
which hair either did not grow back or grew back predom-
inantly gray (Figure 6B; Figure S5B), implying the depletion
of hair bulb melanocytes. Histological examination re-
vealed that hair shaft developmental defects in ATRmKO
regions were preceded by delays in follicle formation in
early anagen (Figure 6A, third depilation). In contrast, the
hair in 4-OHT-treated regions of ATRflox/+Cre-ERT2+ con-
trol mice grew back normally following the second and
third depilation. These data demonstrate that ATR dele-
tion leads to significant defects in hair follicle regeneration.
Hair follicle regeneration is governed by stem cells that
reside in the follicle bulge (Morris et al., 2004). Normally,
anagen induction by depilation causes apoptotic cell
death of a fraction of follicle bulge stem cells and the pro-
liferation of the remaining stem and progenitor cells in the
bulge and secondary germ. These cells begin to divide
within 24 hr and continue to proliferate for at least four ad-
ditional days to self-renew and form the new lower anagen
follicle (Ito et al., 2004). To assess bulge stem cell abun-
dance in ATRmKO and control skin following depilation,
CD34 staining (Blanpain et al., 2004) was used. Prior to
depilation, the representation of telogen-phase follicle
bulge stem cells was similar between ATRmKO and control
skin (Figure 7A). However, 4 days after depilation, while the
follicle bulge stem cell compartment in the control skin was
maintained in the expected manner, a significant depletionof stem cells in the follicles of ATRmKO skin was observed
(Figures 7A and 7B). Subsequently, bulge stem cells in
many follicles were restored with delayed kinetics in
ATRmKO skin (data not shown). This restoration presum-
ably allowed for the delayed regeneration of most hair fol-
licles following the first round of depilation (Figure 7C).
However, after three rounds of depilation, the continued in-
ability of stem cell compartments to self-renew appropri-
ately in ATRmKO skin (Figures 7A and 7B) correlated with
the degeneration of hair follicles (Figures 6A, 6B, and 7C;
Figure S5C) as well as significant delays in hair shaft devel-
opment in the surviving hair follicles (data not shown). In
contrast, stem cell and hair regeneration was normal in
the 4-OHT-treated ATRflox/+Cre-ERT2+ control skin after
three rounds of depilation (Figure 7). Together, these re-
sults demonstrate that alopecia and hair graying observed
inATRmKO mice correlate with a progressive loss of regen-
erative capacity and stem cells in hair follicles.
These studies indicate that loss of tissue homeostasis
and regenerative capacity in the thymus and hair follicles
of ATR knockout mice correlates with a loss of stem and
progenitor cells. Although the mosaic nature of ATR dele-
tion affords some reconstitution of these tissues, the
inability of ATRD/ cells to contribute to regeneration
appeared to effectively shorten the time in which homeo-
stasis and regeneration can be maintained in the lives of
these animals. The implications of these findings on the
cause of premature aging phenotypes in ATRmKO mice
are discussed below.
DISCUSSION
We have shown that deletion of the developmentally es-
sential ATR checkpoint kinase and the subsequent loss
of ATR knockout cells in adult mice lead to the exhaustion
of tissue renewal and homeostatic capacity and the pre-
mature onset of age-related phenotypes. Distinct from
other mouse models of aging, the age-related phenotypes
observed in our studies are not influenced by or the direct
result of developmental abnormalities. Therefore, our
studies imply that reduced regenerative capacity in adults
may be sufficient to cause the appearance of age-related
phenotypes. The implications of these observations on the
role of developmentally essential DDR genes in preserving
regenerative capacity and preventing age-related
diseases are discussed below.
Effect of ATR Loss on Tissue Homeostasis
and Regeneration
Previously, ATR has been shown to be required for embry-
onic development prior to gastrulation and to be indis-
pensable for cellular proliferation in cultured cells (Brown
and Baltimore, 2000, 2003; Cortez et al., 2001). Herein,
we have shown that ATR is essential for continued cellular
proliferation in vivo in the mouse (Figure 4). Importantly,
the inability of ATRD/ cells to proliferate correlated with
the deterioration of several tissues in a manner that resem-
bled premature aging. These data imply that aging pheno-
types inATRmKO mice result from the proliferative failure ofCell Stem Cell 1, 113–126, July 2007 ª2007 Elsevier Inc. 121
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ATR Deletion Causes Aging PhenotypesFigure 6. ATR Deletion Causes Dysfunctional Hair Follicle Regenerative Cycling
(A) Formation of the new lower hair follicle was delayed after the first depilation (n = 5 mice for each time point) and frequently defective after the third
depilation in ATRmKO skin (n = 3 mice for each time point) (arrows). ATR was deleted in 50 to 55-day-old mice by topical treatment of 4-OH-tamoxifen
on 2–3 cm2 of dorsal skin. Four days later, hair shafts (telogen phase) were plucked in the treated areas. Second and third rounds of depilation were
performed in subsequent telogen phases. H&E-stained histological sections of control andATRmKO skins 4 and 8 days after depilation are shown; four
to ten sections were analyzed per mouse. Sg, sebaceous gland; bu, bulge; dp, dermal pappila.
(B) Alopecia and graying of hair in ATRmKO skin 3–4 weeks after the first, second, and third rounds of depilation (arrows). Depilated areas are marked
by hatched lines. Defective hair regrowth was observed in all ATRmKO mice (n = 3–7 for each time point), but not in control mice (n = 3–8).ATRD/ cells and the consequential deficiencies in tissue
regeneration.
Despite the proliferative failure of ATRD/ cells, ATRmKO
mice are not completely devoid of regenerative potential.
While ATRD/ cells were lost particularly from tissues with
constitutive cell proliferation, many of these same tissues
were later reconstituted with cells that escaped lox re-
combination (Figures 3–7). Thus, aging phenotypes were122 Cell Stem Cell 1, 113–126, July 2007 ª2007 Elsevier Inc.observed in ATRmKO despite ample tissue reconstitution
with ATR-expressing cells. For example, after an initial
drop in cellularity following ATR deletion, the ATRmKO
thymi were reconstituted within 3–4 months with cells
that failed to undergo lox recombination and remained
ATRflox/- (Figure 4D). Subsequently, however, the cellular-
ity of ATRmKO thymi dropped below control levels (Fig-
ure 3A). Therefore, in the end, the inability of ATRmKO
Cell Stem Cell
ATR Deletion Causes Aging PhenotypesFigure 7. ATR Deletion Leads to Bulge Stem Cell and Follicle Loss after Depilation
(A) Bulge stem cells were detected by CD34 immunohistochemistry (green) in telogen phase (before depilation) and anagen phase (4 days after the
first and third depilations) follicles; nuclei were detected with DAPI (blue). Significant loss and delayed regeneration of follicle bulge stem cells were
observed in ATRmKO skin following depilation, while the bulge regenerated normally in the control mice (arrows). All pictures were taken at 1003
magnification.
(B) Quantification of the data presented in (A). Two mice per group and eight skin sections per mouse were used, and at least 12 follicles per section
were analyzed.
(C) Quantification of the average number of follicles per 1 mm of skin in control and ATRmKO mice before depilation and 4–6 weeks after each dep-
ilation. H&E-stained skin sections were used. A significant decrease in follicle density inATRmKO skin (n = 2–4 for each group) was observed. Error bars
represent SEM. *p < 0.001 as calculated by Student’s t test.mice to maintain thymopoiesis at normal levels resulted
from the failure of cells that continued to express ATR. In-
sufficient tissue homeostasis as governed by residual
ATR-expressing cells is also the likely cause of deteriora-
tion in other tissues (Figures 2, 3, and 6) and, in somecases, was accompanied by replacement via fibrosis
(Figure S2). As discussed below, loss of regenerative ca-
pacity in ATRmKO mice correlated with stem cell attrition,
providing a potential mechanism for loss of regenerative
capacity and the emergence of age-related phenotypes.Cell Stem Cell 1, 113–126, July 2007 ª2007 Elsevier Inc. 123
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Loss of tissue homeostasis through stem and progenitor
cell attrition has previously been proposed as a model to
explain the general organismal decline associated with
aging (Chen, 2004; Pelicci, 2004; Rando, 2006; Sharpless
and DePinho, 2004; Van Zant and Liang, 2003). Because
ATR deletion led to the depletion of stem and progenitor
cells, our results indicate that stem and progenitor cell at-
trition may be the primary cause of reduced regenerative
capacity in ATRmKO mice. Although alternative explana-
tions are certainly possible, accelerated stem cell and
progenitor cell attrition provides a simple model for the ho-
meostatic and regenerative failure in ATRmKO mice. In
general support of this model, apoptosis (Kujoth et al.,
2005) and p16- and p21-mediated senescence (Choud-
hury et al., 2007; Janzen et al., 2006; Krishnamurthy
et al., 2006; Molofsky et al., 2006) of stem and progenitor
cells have been shown recently to be strongly associated
with several age-related phenotypes in mice. The causes
of stem and progenitor cell reduction in ATRmKO mice are
not clear at the present time but may result from the rep-
licative incompetence of ATR-deleted cells or indirectly
from niche deterioration. Evidence in support of each of
these models is described below.
ATR deletion may render a majority of stem cells replica-
tion incompetent, leading to an overreliance on the re-
maining ATR-expressingATRflox/ stem cells that escaped
lox recombination. These surviving ATR-expressing stem
and progenitor cells may subsequently be lost either by
natural causes or by additional replicative stress acquired
during pool regeneration; thus, these cells may be insuffi-
cient to maintain tissue homeostasis over the long term.
In support of this model, we observed a dramatic loss
of CD34+ follicle bulge stem cells soon after depilation-
induced anagen. While these bulge stem cells re-
generated to a sufficient degree to drive a delayed anagen
phase, they recovered poorly in subsequent regenerative
cycles, and their depletion was ultimately associated
with follicle degeneration and hair loss (Figures 6 and 7).
Stem and progenitor cell attrition by such means may
also contribute to reduced LSK and ETP abundance (Fig-
ure 5), the downstream progeny of which were almost
entirely composed of ATR-expressing ATRflox/ cells
(Figure 4D).
In addition to stem cell exhaustion, decreased regener-
ative capacity in ATRmKO mice may result from deteriora-
tion of the stem cell niche, which maintains stem cells and
regulates the production of downstream progenitor cells.
Such a mechanism may contribute to decreased LSK
abundance in ATRmKO mice (Figure 5A), since the volume
of trabecular bone, which is proposed to be a hematopoi-
etic stem cell niche (Wilson and Trumpp, 2006), is reduced
in these mice (Figure 2C). In addition, deterioration of the
thymic epithelial stroma could contribute to the observed
decreases in ETPs; thus, the dramatic effect of ATR dele-
tion on ETP numbers may result from the combined
effects of LSK reduction and thymic stromal deterioration.
These mechanisms, stem cell exhaustion and niche
deterioration, may each be at work and may synergisti-124 Cell Stem Cell 1, 113–126, July 2007 ª2007 Elsevier Inc.cally decrease stem and progenitor cell potential and tis-
sue regeneration capacity in ATRmKO mice.
ATRmKO Mice and Seckel Syndrome
In humans, hypomorphic mutations in the ATR gene have
been linked to Seckel syndrome, a disease characterized
by intrauterine and postnatal growth retardation, micro-
cephaly, mental retardation, and dysmorphic facial and
skeletal features (O’Driscoll and Jeggo, 2006; O’Driscoll
et al., 2003). The nature of these characteristics suggests
that abnormalities in development are the predominant
cause of these Seckel-associated disorders (O’Driscoll
and Jeggo, 2006). Our results are consistent with this hy-
pothesis, as postdevelopment elimination of ATR resulted
in few of the above characteristics. For example, ATR
deletion in postmitotic neurons had little or no effect on
neurological function (Figure S3), arguing against a role
for ATR in maintaining postmitotic arrest as previously
suggested (O’Driscoll and Jeggo, 2003). Our results sup-
port a model in which the major disorders associated
with Seckel syndrome are predominantly caused by irreg-
ularities during development, possibly as a consequence
of defects in cellular proliferation.
Nevertheless, other characteristics of Seckel syndrome
that are normally overshadowed by the above develop-
mental abnormalities have been reported. For example,
a senile, or progeroid, appearance has frequently been
noted in Seckel patients (Arnold et al., 1999; Boscherini
et al., 1981; Butler et al., 1987; Fathizadeh et al., 1979);
however, this aspect has been difficult to distinguish
from the effects of growth retardation. Hematopoietic ab-
normalities (pancytopenia) have been reported in approx-
imately 20% of patients (Arnold et al., 1999; Butler et al.,
1987), and hair graying and alopecia have been observed
in a few cases (Boscherini et al., 1981; Fathizadeh et al.,
1979). The variance in appearance of these characteristics
is partly due to the use of broad diagnostic parameters but
may also be influenced by genetic heterogeneity, since
mutations in genes other than ATR are associated with
Seckel (Ch. 14q21-q22 and Ch. 18p11.31-q11.2, OMIM).
It is important to note that the penetrance and expressivity
of these minor Seckel phenotypes would not be expected
to reach the level observed in ATRmKO mice given the hy-
pomorphic nature of the ATR mutation in Seckel patients.
Should any of the phenotypes observed in ATRmKO mice
be mirrored in the subset of Seckel patients that harbor
mutations in the ATR gene, then it is possible that these
abnormalities may be rooted in a postdevelopmental
effect of ATR mutations on tissue homeostasis and
regeneration in these individuals.
ATRmKO and Other DDR Mutant Mouse Models
As described above, germline mutations in a number of
DDR genes lead to premature aging phenotypes (Hasty
et al., 2003; Lombard et al., 2005). Interestingly, the pene-
trance, expressivity, and speed of onset of aging pheno-
types were frequently greater in ATRmKO mice than in
other DDR mutant mouse models. While most phenotypes
in ATRmKO mice were observed within 6 months of ATR
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played age-related phenotypes only after 12–18 months
(Hasty et al., 2003; Lombard et al., 2005). In light of our
studies, it is possible that premature aging phenotypes
in DDR mutants are generally determined by the impor-
tance of the gene in maintaining cell viability and tissue ho-
meostasis in adulthood. The rapid onset of age-related
phenotypes observed in XPDR722W/R722W (3 months to
1 year after birth) are consistent with this theory, as this
model harbors a potent hypomorphic mutation in an oth-
erwise essential gene (de Boer et al., 2002). Thus, the es-
sential functions of XPD and ATR under normal physio-
logic conditions prevent aging by maintaining cell
viability and proliferation. Deletion ofATR using the mouse
model system described herein brings about an extreme
effect on cell proliferation in adulthood previously not pos-
sible with germline mutants. As described above, a simple
explanation for the ultimate failure of tissue homeostasis in
ATRmKO mice is the depletion of stem and progenitor cell
pools. If true, the importance of a given DDR gene in pre-
venting aging phenotypes will be directly related to its im-
portance in maintaining genome integrity and the viability
of stem cells. Because the inducible system described
herein may be adapted to delete DDR genes in a tissue-
specific or cell type-specific manner, such systems in
combination with lox recombination reporter alleles may
be used to examine cellular turnover rates during tissue
homeostasis and the importance of specific stem and pro-
genitor compartments in preventing age-related disease
in adult animals.
EXPERIMENTAL PROCEDURES
Generation of Cre-ERT2 Lentitransgenic Mice
The Cre-ERT2 mouse line was generated through lentitransgenesis
(Lois et al., 2002) by microinjection of Cre-ERT2-expressing lentivirus
(100,000 TU/ml) into the perivitelline space of one-cell zygotes
(129SvEv/C57BL/6 mixed). After 3 days in culture, morula and blasto-
cyst stage embryos (12–20) were implanted into each pseudopregnant
recipient mouse. Integrated copies of the recombinant lentivirus in the
resulting 22 founder mice were detected by Southern blotting of HpaI-
digested tail DNA and hybridization to radiolabeled DNA encoding Cre
recombinase. Expression of Cre-ERT2 in founders with single-copy in-
tegrants was confirmed by western blot detection using 1:2000 dilution
anti-Cre polyclonal antisera (Novagen).
Deletion of ATR in Adult Mice
To recombine theATRflox allele using theCre-ERT2 transgenic system,
TAM (MP Biomedicals) was solubilized at 20 mg/ml in a mixture of 98%
corn oil and 2% ethanol and delivered into mice by intraperitoneal
injection or oral gavage treatment (0.5 mM/g body weight, once per
day for 5 days). Lactated Ringer’s solution (hydration) was delivered
by subcutaneous injection when necessary. Southern blot detection
and quantification of ATR+, ATRflox, and ATRD alleles were performed
as described in the Supplemental Experimental Procedures.
Histological Analysis and Immunofluorescence
Tissues were fixed in 4% paraformaldehyde at 4C overnight, dehy-
drated, and embedded in paraffin. For general morphology, tissues
were sectioned and stained with hematoxylin and eosin (H&E). For pro-
liferation analysis, mice were treated with BrdU (1 mg/ml in drinking
water) for 1 month prior to sacrifice. For stromal staining, thymuses
were collected and frozen fresh in OCT compound (VWR). Antibodiesused for detection are described in the Supplemental Experimental
Procedures.
Bone X-Ray, MicroCT, and Histomorphometry
Mice were imaged by X-ray (MP500 High Frequency, Universal). For
histological analysis, bones were fixed in 4% paraformaldehyde at
4C overnight, dehydrated, and stored in 70% EtOH. Bones were
scanned and histomorphometry was performed at the MicroCT Facility
and the Center of Bone Histology and Histomorphometry of the
University of Connecticut, respectively.
Analysis of Hematopoietic Tissues
Harvested thymi were dissociated into single-cell suspensions, and
cells were counted by hemacytometer. Bone marrow was flushed
from the hindlimbs and red blood cells were lysed using ACK lysing
buffer (Cambrex). Bone marrow cells and thymocytes were stained
as described in the Supplemental Experimental Procedures. Dead
cells were excluded with 4,6-diamidino-2-phenylindole (DAPI). Cells
were analyzed on a four-laser LSR II (Becton Dickinson), and cytomet-
ric data were analyzed using FlowJo (Tree Star).
Depilation
Fifty- to fifty-five-day-old (telogen phase) ATRflox/+Cre-ERT2+ control
and ATRflox/-Cre-ERT2+ test mice were topically treated on 2–3 cm2
of dorsal skin with 4-OH-tamoxifen dissolved in 100% EtOH (4 mmol
once per day for 2 days; Alexis Biochemicals). Four days later, hair
in the treated areas was manually plucked. The same skin areas
were then depilated for the second and third time when in telogen
(45–50 days after depilation). Treated and depilated skins were col-
lected at several time points after the first and the third depilations.
Skins were fixed in 4% paraformaldehyde at 4C overnight, processed
for paraffin embedding, and then sectioned and stained for H&E and
CD34 (Supplemental Experimental Procedures).
Supplemental Data
Supplemental Data include Supplemental Experimental Procedures,
five figures, one table, and Supplemental References and can be found
with this article online at http://www.cellstemcell.com/cgi/content/full/
1/1/113/DC1/.
ACKNOWLEDGMENTS
Due to space limitations and the broad scope of this paper, we were
often unable to cite primary research literature; we thank the authors
for their understanding of the use of reviews. We also thank the follow-
ing individuals for their expert advice and assistance in the indicated
areas and for reagents: Douglas Adams and Gloria Gronowicz (bone
analysis at the University of Connecticut MicroCT Facility and Center
for Histology and Histomorphometry); David Baltimore, Carlos Lois,
and Shirley Pease (lentitransgenesis); Mayumi Ito (hair regeneration
experiments); Maja Bucan (behavioral analysis of ATRflox/Syn-Cre+
mice); Qian-Chun Yu, the Abramson Family Cancer Research Institute
(AFCRI) histology core facility and Susan Bender (tissue processing
and analysis); Martin Carroll (PBL analysis); Lawrence Donehower,
Manuel Serrano, Manuel Collado, Pier Paolo Pandolfi, and Zhenbang
Chen (detection of senescence markers p21 and SA-b-gal); Igor
Kuznetsov (statistical analysis); Pierre Chambon (Cre-ERT2 cDNA);
and Brad Johnson and Ben Stanger (critical reading of the manuscript).
Financial support of these studies was provided by the National Insti-
tute on Aging (1R01AG027376-01), AFCRI, and the General Motors
Cancer Research Scholars Program.
Received: February 7, 2007
Revised: March 15, 2007
Accepted: March 28, 2007
Published: June 6, 2007Cell Stem Cell 1, 113–126, July 2007 ª2007 Elsevier Inc. 125
Cell Stem Cell
ATR Deletion Causes Aging PhenotypesREFERENCES
Alonso, L., and Fuchs, E. (2006). The hair cycle. J. Cell Sci. 119, 391–
393.
Arnold, S.R., Spicer, D., Kouseff, B., Lacson, A., and Gilbert-Barness,
E. (1999). Seckel-like syndrome in three siblings. Pediatr. Dev. Pathol.
2, 180–187.
Blanpain, C., Lowry, W.E., Geoghegan, A., Polak, L., and Fuchs, E.
(2004). Self-renewal, multipotency, and the existence of two cell pop-
ulations within an epithelial stem cell niche. Cell 118, 635–648.
Boscherini, B., Iannaccone, G., La Cauza, C., Mancuso, G., Girotti, F.,
Finocchi, G., and Pasquino, A.M. (1981). Intrauterine growth retarda-
tion. A report of two cases with bird-headed appearance, skeletal
changes and peripheral GH resistance. Eur. J. Pediatr. 137, 237–242.
Brown, E.J., and Baltimore, D. (2000). ATR disruption leads to chromo-
somal fragmentation and early embryonic lethality. Genes Dev. 14,
397–402.
Brown, E.J., and Baltimore, D. (2003). Essential and dispensable roles
of ATR in cell cycle arrest and genome maintenance. Genes Dev. 17,
615–628.
Butler, M.G., Hall, B.D., Maclean, R.N., and Lozzio, C.B. (1987). Do
some patients with Seckel syndrome have hematological problems
and/or chromosome breakage? Am. J. Med. Genet. 27, 645–649.
Cao, L., Li, W., Kim, S., Brodie, S.G., and Deng, C.X. (2003). Senes-
cence, aging, and malignant transformation mediated by p53 in mice
lacking the Brca1 full-length isoform. Genes Dev. 17, 201–213.
Casper, A.M., Nghiem, P., Arlt, M.F., and Glover, T.W. (2002). ATR
regulates fragile site stability. Cell 111, 779–789.
Chao, C., Herr, D., Chun, J., and Xu, Y. (2006). Ser18 and 23 phosphor-
ylation is required for p53-dependent apoptosis and tumor suppres-
sion. EMBO J. 25, 2615–2622.
Chen, J. (2004). Senescence and functional failure in hematopoietic
stem cells. Exp. Hematol. 32, 1025–1032.
Choudhury, A.R., Ju, Z., Djojosubroto, M.W., Schienke, A., Lechel, A.,
Schaetzlein, S., Jiang, H., Stepczynska, A., Wang, C., Buer, J., et al.
(2007). Cdkn1a deletion improves stem cell function and lifespan of
mice with dysfunctional telomeres without accelerating cancer forma-
tion. Nat. Genet. 39, 99–105.
Cortez, D., Guntuku, S., Qin, J., and Elledge, S.J. (2001). ATR and
ATRIP: partners in checkpoint signaling. Science 294, 1713–1716.
de Boer, J., Andressoo, J.O., de Wit, J., Huijmans, J., Beems, R.B., van
Steeg, H., Weeda, G., van der Horst, G.T., van Leeuwen, W., Them-
men, A.P., et al. (2002). Premature aging in mice deficient in DNA repair
and transcription. Science 296, 1276–1279.
de Klein, A., Muijtjens, M., van Os, R., Verhoeven, Y., Smit, B., Carr,
A.M., Lehmann, A.R., and Hoeijmakers, J.H. (2000). Targeted disrup-
tion of the cell-cycle checkpoint gene ATR leads to early embryonic le-
thality in mice. Curr. Biol. 10, 479–482.
Fathizadeh, A., Soltani, K., Medenica, M., and Lorincz, A.L. (1979).
Pigmentary changes in Seckel’s syndrome. J. Am. Acad. Dermatol.
1, 52–54.
Feil, R., Wagner, J., Metzger, D., and Chambon, P. (1997). Regulation
of Cre recombinase activity by mutated estrogen receptor ligand-
binding domains. Biochem. Biophys. Res. Commun. 237, 752–757.
Hasty, P., Campisi, J., Hoeijmakers, J., van Steeg, H., and Vijg, J.
(2003). Aging and genome maintenance: lessons from the mouse?
Science 299, 1355–1359.
Ito, M., Cotsarelis, G., Kizawa, K., and Hamada, K. (2004). Hair follicle
stem cells in the lower bulge form the secondary germ, a biochemically
distinct but functionally equivalent progenitor cell population, at the
termination of catagen. Differentiation 72, 548–557.
Janzen, V., Forkert, R., Fleming, H.E., Saito, Y., Waring, M.T.,
Dombkowski, D.M., Cheng, T., DePinho, R.A., Sharpless, N.E., and126 Cell Stem Cell 1, 113–126, July 2007 ª2007 Elsevier Inc.Scadden, D.T. (2006). Stem-cell ageing modified by the cyclin-depen-
dent kinase inhibitor p16INK4a. Nature 443, 421–426.
Kipling,D.,Davis,T.,Ostler,E.L.,andFaragher,R.G. (2004).Whatcanproge-
roid syndromes tell us about human aging? Science 305, 1426–1431.
Krishnamurthy, J., Ramsey, M.R., Ligon, K.L., Torrice, C., Koh, A.,
Bonner-Weir, S., and Sharpless, N.E. (2006). p16INK4a induces an
age-dependent decline in islet regenerative potential. Nature 443,
453–457.
Kujoth, G.C., Hiona, A., Pugh, T.D., Someya, S., Panzer, K., Wohlge-
muth, S.E., Hofer, T., Seo, A.Y., Sullivan, R., Jobling, W.A., et al.
(2005). Mitochondrial DNA mutations, oxidative stress, and apoptosis
in mammalian aging. Science 309, 481–484.
Lois, C., Hong, E.J., Pease, S., Brown, E.J., and Baltimore, D. (2002).
Germline transmission and tissue-specific expression of transgenes
delivered by lentiviral vectors. Science 295, 868–872.
Lombard, D.B., Chua, K.F., Mostoslavsky, R., Franco, S., Gostissa, M.,
and Alt, F.W. (2005). DNA repair, genome stability, and aging. Cell 120,
497–512.
Lopes, M., Cotta-Ramusino, C., Pellicioli, A., Liberi, G., Plevani, P.,
Muzi-Falconi, M., Newlon, C.S., and Foiani, M. (2001). The DNA repli-
cation checkpoint response stabilizes stalled replication forks. Nature
412, 557–561.
Min, H., Montecino-Rodriguez, E., and Dorshkind, K. (2004). Reduc-
tion in the developmental potential of intrathymic T cell progenitors
with age. J. Immunol. 173, 245–250.
Molofsky, A.V., Slutsky, S.G., Joseph, N.M., He, S., Pardal, R., Krish-
namurthy, J., Sharpless, N.E., and Morrison, S.J. (2006). Increasing
p16INK4a expression decreases forebrain progenitors and neurogen-
esis during ageing. Nature 443, 448–452.
Morris, R.J., Liu, Y., Marles, L., Yang, Z., Trempus, C., Li, S., Lin, J.S.,
Sawicki, J.A., and Cotsarelis, G. (2004). Capturing and profiling adult
hair follicle stem cells. Nat. Biotechnol. 22, 411–417.
Nabarra, B., and Andrianarison, I. (1996). Ultrastructural study of thy-
mic microenvironment involution in aging mice. Exp. Gerontol. 31,
489–506.
O’Driscoll, M., and Jeggo, P.A. (2003). Clinical impact of ATR check-
point signalling failure in humans. Cell Cycle 2, 194–195.
O’Driscoll, M., and Jeggo, P.A. (2006). The role of double-strand break
repair—insights from human genetics. Nat. Rev. Genet. 7, 45–54.
O’Driscoll, M., Ruiz-Perez, V.L., Woods, C.G., Jeggo, P.A., and
Goodship, J.A. (2003). A splicing mutation affecting expression of
ataxia-telangiectasia and Rad3-related protein (ATR) results in Seckel
syndrome. Nat. Genet. 33, 497–501.
Osborn, A.J., Elledge, S.J., and Zou, L. (2002). Checking on the fork:
the DNA-replication stress-response pathway. Trends Cell Biol. 12,
509–516.
Pelicci, P.G. (2004). Do tumor-suppressive mechanisms contribute to or-
ganism aging by inducing stem cell senescence? J. Clin. Invest.113, 4–7.
Rando, T.A. (2006). Stem cells, ageing and the quest for immortality.
Nature 441, 1080–1086.
Sharpless, N.E., and DePinho, R.A. (2004). Telomeres, stem cells,
senescence, and cancer. J. Clin. Invest. 113, 160–168.
Van Zant, G., and Liang, Y. (2003). The role of stem cells in aging. Exp.
Hematol. 31, 659–672.
Wilson, A., and Trumpp, A. (2006). Bone-marrow haematopoietic-
stem-cell niches. Nat. Rev. Immunol. 6, 93–106.
Xue, W., Zender, L., Miething, C., Dickins, R.A., Hernando, E., Krizha-
novsky, V., Cordon-Cardo, C., and Lowe, S.W. (2007). Senescence
and tumour clearance is triggered by p53 restoration in murine liver
carcinomas. Nature 445, 656–660.
Zediak, V.P., and Bhandoola, A. (2005). Aging and T cell development:
interplay between progenitors and their environment. Semin. Immunol.
17, 337–346.
